MYLAN PHARMACEUTICALS ULD v. ASTRAZENECA CANADA INC ET AL
Summary of A-344-11
The following information was obtained from the Federal Court or Federal Court of Appeal websites but is NOT the official version. See links below for the court websites.
Federal Court Type: Appeal (S.27 - Final) - Patent Act
Detected Type: Appeal (S.27 - Final) - Patent Act [from T-1473-09 - S. 18.1 Patented Medicines (Notice of Compliance) Regulations]
Parties and Lawyers:| Party | Firm | Lawyer |
|---|---|---|
| ASTRAZANECA CANADA INC | ||
| ASTRAZENECA UK LIMITED | ||
| MINISTER OF HEALTH (THE) | ||
| MYLAN PHARMACEUTICALS ULC | Osler, Hoskin & Harcourt LLP | WHITE, J BRADLEY |
| Name | Number |
|---|---|
| 1337420 |
Patented Medicine: Anastrozole (Medicinal ingredients are based on automated analysis and should not be relied upon.)
Decisions
| Name | Date | Paragraph |
| Mylan Pharmaceuticals ULC v. AstraZeneca Canada, Inc. 2011 FCA 312 | Nov 17, 2011 | Mylan Pharmaceuticals ULC appeals from a decision of the Federal Court: 2011 FC 1023. The appeal is yet to be heard. Two motions have been brought in this Court, one telling us to go slow and the other telling us to go fast. |
| Mylan Pharmaceuticals ULC v. AstraZeneca Canada Inc. 2012 FCA 109 | Apr 11, 2012 | This is an appeal by Mylan Pharmaceuticals ULC (Mylan) from a decision of the Federal Court, reported at 2011 FC 1023. In that decision, Justice Rennie (Judge) granted an application by AstraZeneca Canada Inc. and AstraZeneca UK Limited (collectively, AstraZeneca) under section 6 of the Patented Medicines (Notice of Compliance) Regulations, SOR/93-133, for an order of prohibition. |
This is an appeal from 2011 FC 1023 in T-1473-09. [Determination of the appeal is based on automated analysis and should not be relied upon.]
Docket Summary (Google Translate to English)
(64) 2013-01-17 - OttawaCertified French translation of the reasons for order / doc. # 42 delivered 17-NOV-2011 filed on 17-JAN-2013
Certified French translation of the order / doc. # 43 delivered 17-NOV-2011 filed on 17-JAN-2013 entered in J. & O. Book, volume 276 page(s) 320 - 322
Certified French translation of the order / doc. # 41 delivered 17-NOV-2011 filed on 17-JAN-2013 entered in J. & O. Book, volume 276 page(s) 318 - 319
Certified French translation of the reasons for judgment / doc. # 59 delivered 11-APR-2012 filed on 19-JUN-2012
Certified French translation of the judgment / doc. # 58 delivered 11-APR-2012 filed on 19-JUN-2012 entered in J. & O. Book, volume 273 page(s) 476 - 477
Memorandum to file from M-J. Montpetit dated 10-MAY-2012 confirming that pages 18 to 20 of AstraZeneca's Compendium have been removed and marked as confidential (see letter: ID 92) placed on file.
Memorandum to file from Registry of the FCA dated 12-APR-2012 transmitting a copy of the Judgment and Reasons for Judgment to Justice Rennie and the Applications section of FC. placed on file.
Acknowledgment of Receipt received from All parties: Mr. Bradley White, Mr. Vincent de Grandpré, Mr. Ingram & Mr. Teza Lwin (All by fax) with respect to the Judgement and Reasons for Judgment dated April 11, 2012 placed on file on 12-APR-2012
Reasons for Judgment rendered by The Honourable Mr. Justice Evans concurred in by The Honourable Madam Justice Sharlow The Honourable Madam Justice Dawson dated 11-APR-2012 The Court's decision is with regard to Appeal Filed on 11-APR-2012
Judgment dated 11-APR-2012 rendered by The Honourable Mr. Justice Evans The Honourable Madam Justice Sharlow The Honourable Madam Justice Dawson Matter considered with personal appearance The Court's decision is with regard to Appeal Result: dismissed Filed on 11-APR-2012 entered in J. & O. Book, volume 272 page(s) 302 - 302 (Final decision)
Letter from the appellant dated 30-MAR-2012 We are counsel for the AstraZeneca parties in this appeal, which was argued before the Court on Tuesday, March 27, 2012, During oral argument compendia were provided to the panel for their assistance. The compendia were marked subject to the protective order. On further reveiw, AstraZeneca has determined that a small portion of AstraZeneca's compendium should have been filed under seal... We enclose five confidential envelopes identifying the pages to be sealed and marked with the appropriate protective order legend. We ask that the Court remove the cited pages and place them in the confidential protion of the file using the enclosed envelopes... received on 30-MAR-2012
This matter comes on for hearing on 27-MAR-2012 at Toronto before The Honourable Mr. Justice Evans The Honourable Madam Justice Sharlow The Honourable Madam Justice Dawson Appearances: Mr.J.Bradley White/613-235-7234 for the appellant Mr.Vincent M.de Grandpré/416-362-2111 for the appellant Mr.Colin B.Ingram/613-232-2486 for the respondent Mr.J.Sheldon Hamilton/416-591-1690 for the respondent Language of Hearing: E Court Usher: Anne Street 27-MAR-2012 Duration: on 27-MAR-2012 from 09:32 to 03:30 Courtroom : Courtroom No. 7-C - Toronto Court Registrar Roland Carryl Total duration: 1d Before the Court: appeal Result: reserved Comments: The Court reserves. Minutes of Hearing entered in Vol. 207 page(s) 123 - 132 Abstract of Hearing placed on file
Astrazeneca's Compendium on behalf of the Respondent filed on 27-MAR-2012
Supplemental book of authorities consisting of 1 volume(s) on behalf of Respondent Filed on 27-MAR-2012 1 copy(ies) for the Court retained by the local office
Compendium of Appellant with indication of service upon Respondent on 27-MAR-2012 filed on 27-MAR-2012
Outline of oral arguments on behalf of the appellant received on 27-MAR-2012
Letter from Vincent de Grandpré,counsel for the Appellant,requesting a break-out room dated 26-MAR-2012 the room is needed for Tuesday,March 27,for the day,capable of accomodating 5 persons. received on 26-MAR-2012
Covering letter from Appellant dated 23-FEB-2012 concerning Doc. Nos. 53 54 placed on file on 23-FEB-2012
Solicitor's certificate of service on behalf of J. Bradley White confirming service of Doc. no. 53 upon Respondents by personal service on 23-FEB-2012 filed on 23-FEB-2012
Joint Book of Authorities consisting of 5 volume(s) on behalf of Appellant Filed on 23-FEB-2012 3 copy(ies) for the Court stored in Ottawa
Covering letter from the Respondents, AstraZeneca dated 30-JAN-2012 concerning ..., we enclose a CD containing the PDF version of ... placed on file on 30-JAN-2012
Letter from the appellant dated 27-JAN-2012 "We are solicitors for the Appellant, Mylan Pharmaceuticals ULC, in the above-noted appeal. Further to the Court's letter dated January 16, 2012, please find enclosed a CD containing an electronic copy of the following documents: (...)" received on 27-JAN-2012
Acknowledgment of Receipt received from the Appellant (Mr. White & Mr. de Grandpré, by fax), the Respondent, AstraZeneca Canada Inc (Mr. Ingram, Mr. Hamilton, by fax) and the Respondent, Minister of Health (Mr. Lwin, by fax) with respect to Order scheduling the Appeal - doc. 52 - placed on file on 27-JAN-2012
Order (time and place) dated 27-JAN-2012 rendered by S. Bazinet, Judicial Administrator and signed by Judicial Administrator fixing Appeal to be heard at Special Sitting in Toronto on 27-MAR-2012 to begin at 09:30 Filed on 27-JAN-2012 cc's sent to parties entered in J. & O. Book, volume 271 page(s) 243 - 243 Transmittal letters placed on file
Communication from Registry to Judicial Administrator dated 16-JAN-2012 re: fixing the date and place for the Hearing (Ott or Tor).
Covering letter from Appellant dated 12-JAN-2012 concerning Doc. Nos. 50 51 placed on file on 12-JAN-2012
Solicitor's certificate of service on behalf of J. Bradley White confirming service of Doc. No. 50 upon Respondents - AstraZeneca Canada, Inc. & AstraZeneca UK Limited by telecopier on 12-JAN-2012 confirming service Doc. No. 50 upon Respondent - Minister of Health by telecopier on 12-JAN-2012 filed on 12-JAN-2012
Requisition for hearing - Appeal from Appellant filed on 12-JAN-2012
Covering letter from Mr. Colin B. Ingram dated 30-DEC-2011 concerning Doc. No. 48 placed on file on 30-DEC-2011
Solicitor's certificate of service on behalf of Colin B. Ingram confirming service of doc. 48 upon Appellant and the Minister of Health by personal service on 30-DEC-2011 filed on 30-DEC-2011
Memorandum of fact and law on behalf of the Respondents, Astrazeneca Canada Inc. and Astrazeneca UK Limited. filed on 30-DEC-2011 3 judges' copies stored in Ottawa
Covering letter from Respondent dated 15-DEC-2011 concerning Doc. No. 47 placed on file on 15-DEC-2011
Consent to Rule 7 extension for filing of Astrazeneca respondent's memorandum on behalf of all parties filed on 15-DEC-2011
Letter sent by Registry on 01-DEC-2011 to be picked up by counsel, Mr. White, from Osler's Ottawa office ..., please find attached five (5) copies of the sealed memorandum of fact and law submitted on November 18, 2011. - Copy placed on file.
Memorandum of fact and law on behalf of the appellant filed on 18-NOV-2011 3 judges' copies stored in Ottawa
Memorandum to file from Elise Benoit dated 30-NOV-2011 re: Notification of parties of the Direction dated November 29, 2011 - placed on file.
Acknowledgment of Receipt received from counsel on behalf of all parties with respect to Direction dated November 29, 2011. Fax transmittal comm. journal placed on file on 30-NOV-2011
Written directions of the Court: The Honourable Madam Justice Dawson dated 29-NOV-2011 directing ... 1. Reutrn the five (5) copies of the sealed memorandum of fact and law submitted by the appellant. 2. File, as of November 18, 2011, the five (5) copies of the non-selaed memorandum of fact and law submitted by the appellant. - received on 30-NOV-2011 Confirmed in writing to the party(ies)
Communication from Registry to Judicial Administrator dated 25-NOV-2011 re: the Appellant's letters dated November 22 & 24, 2011 regarding their public Mememorandum of Fact and Law (to replace the sealed version) that they wish to be accepted for filing as of November 18, 2011. Respectfully submitted for the Court's consideration,
Letter from the appellant dated 24-NOV-2011 advising that the appellant is providing the Court with five copies of the public version of the appellant's memorandum and that the public memorandum is identical to the one filed on November 18, 2011 except that it is not sealed and the confidentiality legend has been removed from the footer on every page. received on 24-NOV-2011
Letter from the appellant dated 22-NOV-2011 "..Last Friday, we therefore contacted counsel for AstraZeneca requesting guidance about which paragraphs in Mylan's Memorandum should be redacted from any publicly-available version. Counsel for AstraZeneca indicated that they would attend to this matter promplty, but that they would likely require until the end of this week to provide guidance..." received on 22-NOV-2011
Solicitor's certificate of service on behalf of J. Bradley White confirming service of 44 upon Respondent by personal service on 18-NOV-2011 filed on 18-NOV-2011
****** REMOVED ****** Sealed envelope pursuant to Order of Federal Court (Milczynski P. in T-1473-09) dated April 14, 2011 on behalf of Appellant purporting to contain the Confidential Memorandum of Fact and Law of the Appellant Filed on 18-NOV-2011
Acknowledgment of Receipt received from Mr. de Grandpré (email), Mr. Hamilton (email) and Mr. Peterson (fax) with respect to the Orders and Reasons for Order of the Court (Stratas J.A.) dated November 17, 2011, placed on file on 21-NOV-2011
Letter from the appellant dated 18-NOV-2011 enclosing five copies of the Confidential Memorandum of Fact and Law of the Appelant, with proof of service. received on 18-NOV-2011
Order dated 17-NOV-2011 rendered by The Honourable Mr. Justice Stratas Matter considered without personal appearance The Court's decision is with regard to the motion / document number 15 Result: dismissed Filed on 17-NOV-2011 copies sent to parties Transmittal Letters placed on file. entered in J. & O. Book, volume 270 page(s) 186 - 187
Reasons for Order rendered by The Honourable Mr. Justice Stratas dated 17-NOV-2011 The Court's decision is with regard to the motion / document number 8 Filed on 17-NOV-2011 Copies sent to parties
Order dated 17-NOV-2011 rendered by The Honourable Mr. Justice Stratas Matter considered without personal appearance The Court's decision is with regard to the motion / document number 8 Result: dismissed Filed on 17-NOV-2011 copies sent to parties Transmittal Letters placed on file. entered in J. & O. Book, volume 270 page(s) 185 - 185
Appeal Book consisting of 14 volume(s) including confidential volume(s) 2 9 10 11 12 13 14 prepared by the appellant filed on 16-NOV-2011 3 judges' copies stored in Ottawa
Covering letter from Appellant dated 16-NOV-2011 concerning Doc. Nos. 37 38 39 placed on file on 16-NOV-2011
Solicitor's certificate of service on behalf of Vincent de Granpré confirming service of Doc. No. 37 upon Respondent - The Minister of Health by by hand on 16-NOV-2011 filed on 16-NOV-2011
Solicitor's certificate of service on behalf of J. Bradley White confirming service of Doc. no.37 upon Respondents - AstraZeneca Canada, Inc. & AstraZeneca UK Limited by by hand on 16-NOV-2011 filed on 16-NOV-2011
****** CANCELLED ****** Agreement as to the content of the Appeal book from the appellant filed on 16-NOV-2011
Communication from Registry to Judicial Administrator dated 15-NOV-2011 re: motions docs. 8 and 15
Covering letter from Astrazeneca Canada Inc. dated 10-NOV-2011 concerning Doc. No. 34 placed on file on 10-NOV-2011
****** CANCELLED ****** Covering letter from Astrazeneca Canada Inc. dated 10-NOV-2011 concerning Doc. No. 34 placed on file on 10-NOV-2011
Solicitor's certificate of service on behalf of Daniel S. Davies confirming service of Doc. 34 upon Appellant by personal service on 10-NOV-2011 filed on 10-NOV-2011
Motion Record in response to Motion Doc. No. 28 containing the following original document(s): 33 Number of copies received: 3 on behalf of Astrazeneca Canada Inc. filed on 10-NOV-2011
Written representations contained within a Motion Record on behalf of Astrazeneca Canada Inc. in opposition to 28 filed on 10-NOV-2011
Covering letter from Appellant dated 04-NOV-2011 concerning Doc. No. 31 placed on file on 04-NOV-2011
Solicitor's certificate of service on behalf of J. Bradley White confirming service of Reply Motion Record (doc.31) upon Respondent by personal service on 04-NOV-2011 filed on 04-NOV-2011
Motion Record in response to Motion Doc. No. 8 containing the following original document(s): 30 Number of copies received: 3 on behalf of Appellant filed on 04-NOV-2011
Written representations contained within a Motion Record on behalf of the appellant in reply to Motion (doc. 8) filed on 04-NOV-2011
Covering letter from Appellant dated 04-NOV-2011 concerning Responding Motion Record (doc. 28) and Book of Authorities placed on file on 04-NOV-2011
Solicitor's certificate of service on behalf of J. Bradley White confirming service of Responding Motion Record and Book of Authorities upon Respondent by personal service on 04-NOV-2011 filed on 04-NOV-2011
Book of Authorities consisting of 1 volume(s) on behalf of Appellant received on 04-NOV-2011 3 copy(ies) for the Court stored in Ottawa
Motion Record in response to Motion Doc. No. 15 containing the following original document(s): 26 27 Number of copies received: 3 on behalf of Appellant filed on 04-NOV-2011
Written representations contained within a Motion Record on behalf of the appellant in opposition to Motion (doc. 15) filed on 04-NOV-2011
Affidavit of Brad Jenkins contained within a Motion Record on behalf of the appellant sworn on 02-NOV-2011 in opposition to Motion (doc. 15) with attached exhibit(s) A & B filed on 04-NOV-2011
Letter from the appellant AstraZeneca Canada Inc. dated 04-NOV-2011 "...I am writing to foramlly request that certain materials that have been filed with the Court be sealed pursuant to the Confidentiality Order in this matter... On October 26, 2011 AstraZeneca Canada Inc. filed a motion in writing to stay the appeal. The motion record included the affidavit of Michael S. duchesneau sworn October 24, 2011... Exhibits "A" and "B" of the Duchesneau affidavit are desigated as confidential information of the Applicants pursuant to the Confidentiality Order. Accordingly, we respectfully request that the Court seal these Exhibits...We respecfully request that the Court seal Exhibits "A" and "B" from the copy of the Duchesneau Affidavit included in the responding motion record filed October 31, 2011." received on 04-NOV-2011
Covering letter from Respondent dated 31-OCT-2011 concerning Doc. Nos. 20 24 25 placed on file on 31-OCT-2011
Solicitor's certificate of service on behalf of Daniel S. Davies confirming service of Motion Record doc # 24 upon all parties by hand on 31-OCT-2011 filed on 31-OCT-2011
Motion Record in response to Motion Doc. No. 8 containing the following original document(s): 21 22 23 Number of copies received: 3 on behalf of Respondent filed on 31-OCT-2011
Written representations contained within a Motion Record on behalf of the appellant in opposition to the Appealant's motion to expedite filed on 31-OCT-2011
Affidavit of Michael Duchesneau contained within a Motion Record on behalf of the respondent sworn on 24-OCT-2011 in opposition to Appealant's Motion to expedite with attached exhibit(s) A B C D E F G H I J K L M filed on 31-OCT-2011
Affidavit of Denise Lacombe contained within a Motion Record on behalf of the respondent sworn on 24-OCT-2011 in opposition to Appealant's motion to expedite with attached exhibit(s) A B C filed on 31-OCT-2011
Consent to a 5 day extension of time for the Respondents to file their motion record in response to the Appealant's motion to expedite the appeal served October 14, 2011. on behalf of All parties filed on 31-OCT-2011
Covering letter from Respondent AstraZeneca dated 26-OCT-2011 concerning Doc. Nos. 18 19 placed on file on 26-OCT-2011
Solicitor's certificate of service on behalf of Daniel S. Davies confirming service of Respondent Astrazeneca's 369 Motion Record doc. no. 18 upon all parties by personal service on 26-OCT-2011 filed on 26-OCT-2011
Motion Record containing the following original document(s): 15 16 17 Number of copies received: 3 on behalf of Respondent AstraZeneca filed on 26-OCT-2011
Written representations contained within a Motion Record on behalf of the respondent AstraZeneca in support of motion doc. 15 filed on 26-OCT-2011
Affidavit of Michael S. Duchesneau on behalf of the respondent AstraZeneca sworn on 24-OCT-2011 in support of motion doc. no. 15 with attached exhibit(s) "A" to "M" filed on 26-OCT-2011
Notice of motion contained within a Motion Record on behalf of the respondent AstraZeneca an order to stay this appeal until a decision of the SCC is rendered in Teva Canda Limited v. Pfizer Canada Inc., et al in writing filed on 26-OCT-2011
Letter from the Respondent, AstraZeneca Canada Inc., et al., dated 24-OCT-2011 further to the Appellant's motion to expedite the appeal, all parties have consented to a 5 day extension of time for the Respondents, AstraZeneca Canada Inc., et al., to file their responding motion record. A formal writen consent will accompany the Respondents' responding motion record. received on 24-OCT-2011
Covering letter from Appellant dated 20-OCT-2011 concerning Doc. No. 14 placed on file on 20-OCT-2011
Agreement as to the content of the Appeal book from the appellant the respondent filed on 20-OCT-2011
Solicitor's certificate of service on behalf of Janet N. Chong confirming service of DOC 12 upon Respondent by process server on 14-OCT-2011 filed on 14-OCT-2011
Motion Record containing the following original document(s): 8 9 10 11 Number of copies received: 3 on behalf of Appellant filed on 14-OCT-2011
Written representations contained within a Motion Record on behalf of the appellant in support of Motion Doc No. 8 filed on 14-OCT-2011
Affidavit of Janet N. Chong on behalf of the appellant sworn on 14-OCT-2011 in support of Motion Doc No. 8 with attached exhibit(s) A B C filed on 14-OCT-2011
Sealed envelope pursuant to confidentiality order dated 14-APR-2010 on behalf of Appellant purporting to contain Affidavit of David E. Blais Filed on 14-OCT-2011
Notice of motion contained within a Motion Record on behalf of the appellant an expedited hearing of this motion; An order that the hearing of this appeal be expedited and set down for a one-day hearing no later than 1-Jun-2012; an order granting Mylan the right to file its requisition for hearing forthwith in writing filed on 14-OCT-2011
Memorandum to the Honourable Justice Rennie and the Federal Court, Application Section, from the Registry of the Federal Court of Appeal dated 27-SEP-2011 forwarding a copy of the Notice of Appeal placed on file.
Affidavit of James Adeney on behalf of Respondent, Minister of Health sworn on 26-SEP-2011 confirming service of doc 6 on the Appellants and the Respondent AstraZeneca Canada Inc. by telecopier on 26-SEP-2011 with attached exhibit(s) A filed on 26-SEP-2011
Notice of appearance on behalf of Respondent, Minister of Health filed on 26-SEP-2011
Covering letter from Respondents AstraZeneca Canada Inc. and AstraZeneca UK Limited dated 26-SEP-2011 concerning Doc. Nos. 4 5 placed on file on 26-SEP-2011
Solicitor's certificate of service on behalf of Colin B. Ingram confirming service of Respondents' Notice of Appearance doc. no. 4 upon all parties by telecopier on 26-SEP-2011 filed on 26-SEP-2011
Notice of appearance on behalf of Respondents AstraZeneca Canada Inc., AstraZeneka UK Limited filed on 26-SEP-2011
Covering letter from Appellant dated 23-SEP-2011 concerning Doc. No. 3 placed on file on 23-SEP-2011
Solicitor's certificate of service on behalf of Brad Jenkins confirming service of document 1 upon Respondents, AstraZeneca Canada Inc. et al, by hand on 23-SEP-2011 filed on 23-SEP-2011
Copy of DOC. 1 with proof of service on Deputy Attorney General of Canada on 23-SEP-2011 filed on 23-SEP-2011
Notice of Appeal and 2 copies filed on 23-SEP-2011 against a decision of the Honourable Mr. Justice Rennie dated August 29, 2011 in court file no. T-1473-09 Certified copy(ies)/copy(ies) transmitted to Deputy Attorney General of Canada Tariff fee of $50.00 received: yes
The official version of the court proceeding information is available from the court websites directly: